What should private equity industry players know about the Public Readiness and Emergency Preparedness (“PREP”) Act? In our third Sidecar episode, product liability and mass torts partner Sara Roitman and associate Monica Gorny discuss the broad liability immunity the Act provides to companies involved in COVID-19 diagnosis, treatment and prevention activities, and how it may reduce litigation risk for PE portfolio companies working to address the global pandemic.